School-Centered Telemedicine for Children with Type 1 Diabetes Mellitus - 09/08/11
Abstract |
Objectives |
To test the feasibility and effectiveness of telemedicine to improve care of children with type 1 diabetes in schools.
Study design |
Subjects, ages 5 to 14 years (grades kindergarten through eighth) were randomized to usual care (18 students; 13 schools) or intervention (23 students; 12 schools). Usual care included medical visits every 3 months and communication between school nurse and diabetes team as needed by phone. The intervention group received usual care plus a telemedicine unit in the school nurse office to videoconference between the school nurse, child, and diabetes team every month. Hemoglobin A1c and pediatric quality of life were measured every 3 months for 1 year. Analyses used multilevel modeling.
Results |
A1c values increased from baseline to 6 months for students in the usual care group and decreased in the telemedicine cohort (P < .02). Lower A1c levels in the telemedicine group were maintained over the next several months, and significant improvements in several subscales of the Pediatric Diabetes Quality of Life questionnaire were observed. In the telemedicine group, urgent diabetes-related calls initiated by the school nurse were significantly reduced, and there were fewer hospitalizations and emergency department visits.
Conclusions |
A school telemedicine program can improve diabetes care in grades kindergarten through eighth.
Le texte complet de cet article est disponible en PDF.Mots-clés : DKA, PedsQL
Plan
| Supported by Department of Health and Human Services (equipment), New York State Department of Health; and the Children’s Miracle Network. LifeScan Inc., donated home glucose monitoring devices and test strips for this project. The authors declare no conflicts of interest. |
|
| ClinicalTrials.gov identifier: NCT00566475. |
|
| No Reprints offered. |
Vol 155 - N° 3
P. 374-379 - septembre 2009 Retour au numéro
Article précédent
- Pramlintide Lowered Glucose Excursions and Was Well-Tolerated in Adolescents with Type 1 Diabetes: Results from a Randomized, Single-Blind, Placebo-Controlled, Crossover Study
- H. Peter Chase, Karen Lutz, Richard Pencek, Bei Zhang, Lisa Porter
- Delayed Diagnosis in Duchenne Muscular Dystrophy: Data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
- Emma Ciafaloni, Deborah J. Fox, Shree Pandya, Christina P. Westfield, Soman Puzhankara, Paul A. Romitti, Katherine D. Mathews, Timothy M. Miller, Dennis J. Matthews, Lisa A. Miller, Christopher Cunniff, Charlotte M. Druschel, Richard T. Moxley
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?